About How I Work The Journey Corporate Wellness Store
Skip to MenoVitality form

Why this tool exists

Where you are in the transition changes everything

Menopause is not a single moment — it's a multi-year transition with at least seven distinct biological stages. Most hormone analyzers ignore this entirely. MenoVitality™ uses STRAW+10 (Harlow et al., 2012) to identify exactly where you are, what your symptoms mean in that context, and what questions to bring to your clinician.

FSH of 30 means different things at different stages

In late perimenopause, FSH at 30 is consistent with the transition. In postmenopause on HRT, FSH at 30 may mean estrogen dosing is appropriate. Stage matters more than the number.

Hormonal volatility, not just deficiency

The most disruptive symptoms during perimenopause come from estradiol swings, not steady low estrogen. A single lab draw catches one moment in a highly variable hormonal environment — pattern reading requires context.

Symptom-biomarker pattern recognition

Vasomotor + sleep + mood + cognitive symptoms cluster predictably with specific biomarker patterns. MenoVitality™ identifies 12 clinically meaningful patterns — including thyroid-masked, hyperprolactin-confounded, and PCOS persisting into midlife.

Surgical menopause, POI, and HRT users

This tool is built for the full spectrum — not just classic perimenopause. Dedicated patterns for surgical menopause, premature ovarian insufficiency (POI), and three distinct HRT-monitoring scenarios.

Don't have lab data yet?

Order Your Hormone Panel Through ULTA Lab Tests

ULTA Lab Tests offers direct-to-consumer hormone panels with no doctor's referral required — typically less than half of insurance billing. Order online, visit a nearby lab, get results in 2–5 business days. Then return to MenoVitality™ to interpret them.

Order Your Hormone Panel → Ask the Doctor — $150 Initial Consult

ULTA Lab Tests not available in NY, NJ, RI, or HI. Affiliate partnership — your purchase helps support free tools on this platform.

Step 1 of 4 · Where are you currently?

Tell us your current status

This helps the analyzer apply the correct stage-specific reference ranges and pattern logic. You can change this answer at any time before submitting.

A note on inclusivity: MenoVitality™ is designed for the cisgender menopause transition. Trans-masculine users on testosterone therapy will receive different reference ranges than this tool provides — we'll route you to a Physician Interpretation Session for personalized guidance that respects both your transition and your longevity health.

Steps 2–4 · Context, Symptoms & Biomarkers

Complete your hormone panel analysis

Required fields are marked with *. Optional fields strengthen the interpretation but aren't required. All fields are processed privately; no information is permanently stored.

Step 2 · Your Context

Information that informs STRAW+10 staging.

Cancer history *

This is required because it directly affects which interventions are safe to consider. Your answer is processed privately and never stored.

Are you trans-masculine on testosterone therapy?

MenoVitality™ reference ranges are designed for the cisgender menopause transition. If you check yes, we'll route you to a Physician Interpretation Session for guidance that respects both your transition and your longevity health.

Step 3 · Symptoms

The Greene Climacteric Scale — the most-cited validated menopause symptom inventory. Rate each item 0 (none) to 3 (severe).

0 = None · 1 = Mild · 2 = Moderate · 3 = Severe

Vasomotor

Hot flushes
Night sweats

Sleep, Mood & Fatigue

Sleep disturbance / waking
Mood swings or irritability
Fatigue or low energy

Sexual / Genitourinary

Vaginal dryness
Loss of libido

Cognitive / Somatic

"Brain fog" or word-finding difficulty
Joint or muscle aches
Anxiety

The Full Greene scale adds 11 lower-yield items. Toggle back to Quick (10 items) if you'd prefer a shorter form.

Additional Somatic

Palpitations
Headaches
Dizziness or lightheadedness
Breast tenderness

Additional Psychological

Depressed mood
Difficulty concentrating

Additional GU / Other

Urinary urgency or frequency
Painful intercourse
Hair thinning
Midsection changes (metabolic shift)
Irritability
Step 4 · Biomarkers

Tier 1 fields are most helpful for staging; Tier 2 and 3 strengthen pattern recognition. All fields are optional but the more data, the more specific the interpretation.

Tier 1 · Core Reproductive Hormones

Tier 2 · Strongly Recommended

Tier 3 · Cardiometabolic Overlay (optional)

AI Use Disclosure · Required Acknowledgment

Before analyzing, please acknowledge:

  • This tool uses AI (Anthropic Claude) to interpret your hormone panel under physician-authored system prompts.
  • This is educational, not diagnostic. It does not establish a physician-patient relationship.
  • This is not a substitute for in-person care. Always consult your clinician before making health decisions.
  • Your data is processed privately. No information is permanently stored after the session.
  • Limitations apply — AI interpretation has known constraints. Consult AI Disclosure for details.

Analyzing Your Hormone Panel

Please wait — do not press back or refresh

  1. 1 Assigning your STRAW+10 stage from menstrual history and biomarkers...
  2. 2 Running the 12-pattern classifier against your symptom-biomarker profile...
  3. 3 Applying stage-appropriate reference ranges and risk overlays...
  4. 4 Generating personalized clinical interpretation from Dr. Kilgore's framework...

This typically takes 30 to 60 seconds — we're applying validated equations and AI clinical analysis.

📚 View Sources & Citations for MenoVitality™

How MenoVitality™ Works — Methodology

STRAW+10 Staging

MenoVitality™ uses the Stages of Reproductive Aging Workshop +10 framework — the international gold standard for staging the menopause transition. STRAW+10 was developed in 2012 by an international consortium and is co-published in Menopause, Climacteric, JCEM, and Fertility & Sterility. It defines seven specific stages spanning late reproductive years through late postmenopause.

Modified Greene Climacteric Scale

Symptom assessment uses a modified version of the Greene Climacteric Scale (Greene 1998), the most-cited validated menopause symptom inventory. Items are organized into four subscales — vasomotor, sleep/mood, sexual/genitourinary, and cognitive/somatic — and rated 0 (none) to 3 (severe). MenoVitality™ offers both a Quick (10-item) and Full (21-item) version.

Pattern Classification Engine

Each user receives a primary pattern (and up to two secondary patterns) from a 12-pattern classifier scored against biomarker, context, and symptom inputs:

  • Classic Perimenopause
  • Early Decline in Ovarian Reserve
  • Surgical Abrupt-Onset Menopause
  • Premature Ovarian Insufficiency (POI)
  • Postmenopausal Cardiometabolic Shift
  • Thyroid-Masked Pattern
  • Elevated Prolactin Confounder
  • Low-Androgen Fatigue/Libido Pattern
  • HRT Under-Optimization
  • HRT Overshoot or Imbalance
  • PCOS Persisting into Midlife
  • Indeterminate — Clinician Review Recommended

Stage-Specific Reference Ranges

Biomarker reference ranges shift with stage. FSH of 30 means something different in late perimenopause vs. in postmenopause on HRT. MenoVitality™ applies stage-appropriate ranges for FSH, estradiol, LH, AMH, and progesterone, alongside universal ranges for thyroid, prolactin, androgens, and cardiometabolic markers.

AI-Assisted Interpretation

Once staging and pattern classification complete, an AI model (Anthropic Claude) generates an educational interpretation under physician-authored system prompts that include strict guardrails: no diagnosis, no prescriptions, no fertility prognosis, no HRT brand/dose recommendations, and explicit emotional warmth for surgical menopause and POI users. Cancer-history flags suppress all systemic HRT mentions. The model uses STRAW+10 anchors and references NAMS (North American Menopause Society) evidence frameworks.

Risk Flag Overlays

Six risk flags are computed (bone health, cardiovascular shift, cognitive-sleep cascade, GSM, cancer-history HRT-suppression, thyroid referral) and drive both the AI prompt context and the conditional cross-tool recommendations shown above. These are decision-support cues, not diagnoses.

Full citations available at drpaulkilgore.com/sources#menovitality.

📚 Educational Use Only

This tool is for informational and educational purposes only. It does not constitute medical advice, diagnosis, or treatment, and does not establish a physician-patient relationship.

🤖 AI Disclosure

Analysis is generated using AI (Anthropic Claude) under physician-authored prompts. Output reflects general clinical frameworks, not personalized medical advice. See AI Use Disclosure for details.

🔒 Privacy

Your data is processed privately. No personal health information is permanently stored after your session. We do not share, sell, or track your inputs.

⚠️ Limitations

A single hormone draw captures one moment of a highly variable hormonal environment. Pattern recognition tools cannot replace longitudinal assessment by a qualified clinician who knows your full history.

♿ Accessibility

This tool meets WCAG 2.2 AA standards. A floating accessibility icon (bottom-right) lets you adjust text size and contrast. Report any issues via our contact page.

🚨 Emergency

If you are experiencing a medical emergency, call 911 or go to the nearest emergency department. Do not use this tool to address urgent or life-threatening symptoms.

Dr. Paul E. Kilgore, MD, MPH, FACP

Board-Certified Internist · CDC EIS-Trained Epidemiologist · 36+ Years Clinical Experience

Quantitative Health LLC — Health Revolutionized™

Licensed in Michigan, Alabama, Missouri, Wisconsin & Pennsylvania

AI Disclosure · Sources · All Tools · Working with Dr. Kilgore